Manipulation of the tumor suppressor p53 for potentiating cancer therapy

被引:33
|
作者
Haupt, S
Haupt, Y [1 ]
机构
[1] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmaceut, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
基金
以色列科学基金会;
关键词
p53; Mdm2; therapy; DNA damage; small molecules;
D O I
10.1016/j.semcancer.2004.04.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor suppressor p53 is a linchpin in the regulation of appropriate cellular responses to various stress conditions. Inactivation of the functions of this critical participant can have diabolical consequences, in particular the development of malignant diseases. Elicitation of appropriate p53 functions is an attractive strategy for combating cancer. Triggering p53 responses, reconstituting p53 activities through gene therapy, coercing mutant p53 to perform normal functions, manipulating p53 regulators, and activating p53 effectors are all approaches that are currently being developed. Here, we will overview 'p53-based' strategies for fighting cancer, both those under clinical trial and recent innovative concepts. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:244 / 252
页数:9
相关论文
共 50 条
  • [1] p53 tumor suppressor gene therapy for cancer
    Nielsen, LL
    Maneval, DC
    [J]. CANCER GENE THERAPY, 1998, 5 (01) : 52 - 63
  • [2] p53 tumor suppressor gene therapy for cancer
    Roth, JA
    Swisher, SG
    Meyn, RE
    [J]. ONCOLOGY-NEW YORK, 1999, 13 (10): : 148 - 154
  • [3] Tumor suppressor p53 gene: a potential target for cancer therapy?
    Soussi, T
    [J]. BULLETIN DU CANCER, 1997, 84 (07) : 753 - 756
  • [4] TARGETING THE P53 TUMOR SUPPRESSOR PATHWAY FOR IMPROVED CANCER THERAPY
    Wiman, K. G.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 : 8 - 8
  • [5] Potential of rescue and reactivation of tumor suppressor p53 for cancer therapy
    Emi Hibino
    Hidekazu Hiroaki
    [J]. Biophysical Reviews, 2022, 14 : 267 - 275
  • [6] Potential of rescue and reactivation of tumor suppressor p53 for cancer therapy
    Hibino, Emi
    Hiroaki, Hidekazu
    [J]. BIOPHYSICAL REVIEWS, 2022, 14 (01) : 267 - 275
  • [7] The tumor suppressor p53 - Cancer and aging
    Feng, Zhaohui
    Hu, Wenwei
    Rajagopal, Gunaretnam
    Levine, Arnold J.
    [J]. CELL CYCLE, 2008, 7 (07) : 842 - 847
  • [8] p53 tumor suppressor gene: Implications for iatrogenic cancer and cancer therapy
    DeBenedetti, V
    Bennett, WP
    Greenblatt, MS
    Harris, CC
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1996, : 2 - 11
  • [9] Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities
    Hong, Bo
    van den Heuvel, A. Pieter J.
    Prabhu, Varun V.
    Zhang, Shengliang
    El-Deiry, Wafik S.
    [J]. CURRENT DRUG TARGETS, 2014, 15 (01) : 80 - 89
  • [10] Targeting tumor suppressor p53 for organ fibrosis therapy
    Bao, Yi-Ni
    Yang, Qiao
    Shen, Xin-Lei
    Yu, Wen-Kai
    Zhou, Li
    Zhu, Qing-Ru
    Shan, Qi-Yuan
    Wang, Zhi-Chao
    Cao, Gang
    [J]. CELL DEATH & DISEASE, 2024, 15 (05):